Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

November 27, 2013

Systematically in silico comparison of unihormonal and bihormonal artificial pancreas systems. Free full text available in HTML and PDF formats.
Assessment of Type 1 Diabetes Risk Conferred by HLA-DRB1, INS-VNTR and PTPN22 Genes Using the Bayesian Network Approach. Free full text available in HTML and PDF formats.
Generation of Functional Insulin-Producing Cells from Neonatal Porcine Liver-Derived Cells by PDX1/VP16, BETA2/NeuroD and MafA. Free full text available in HTML and PDF formats.

November 20, 2013

Feasibility of a Portable Bihormonal Closed-Loop System to Control Glucose Excursions at Home Under Free-Living Conditions for 48 Hours.
Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment. Free full text available in HTML and PDF formats.
Recruitment and retention of participants for an international type 1 diabetes prevention trial: A coordinators’ perspective.
Vitamin D at the onset of type 1 diabetes in Italian children.
Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. Free full text available in HTML and PDF formats. See also Gluten Changes Microbiome, Increases Type 1 Diabetes.

November 13, 2013

Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
The Association between Vitamin D and Vascular Stiffness in Adolescents with and without Type 1 Diabetes. Free full text available in HTML and PDF formats.
Treatment of Autoimmune Diabetes by Inhibiting the Initial Event. Free full text available in HTML and PDF formats.
Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of Glucagon-Like Peptide (GLP)-1-Based Therapies.

November 6, 2013

Transplantation of human islets without immunosuppression.
The trends and the risk of type 1 diabetes over the past 40 years: an analysis by birth cohorts and by parental migration background in Sweden. Free full text available in HTML and PDF formats.
Genetic and Epigenetic Factors in Etiology of Diabetes Mellitus Type 1.

October 30, 2013

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose.
Day and Night Closed-Loop Control in Adults With Type 1 Diabetes Mellitus.
Artificial Pancreas Using a Personalized Rule-Based Controller Achieves Overnight Normoglycemia in Patients with Type 1 Diabetes.
Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry.
Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes mellitus.

October 23, 2013

Finnish team makes diabetes vaccine breakthrough, Key discovery raises hope of jab to beat diabetes, and New Evidence for Role of Specific Virus Causing Type 1 Diabetes reference Virus Antibody Survey in Different European Populations Indicates Risk Association Between Coxsackievirus B1 and Type 1 Diabetes, previously reported.
Effectiveness of Early Intensive Therapy on beta-Cell Preservation in Type 1 Diabetes.
Model-Based Closed-Loop Glucose Control in Type 1 Diabetes: The DiaCon Experience.
Patterns of beta-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life.
Vitamin C Further Improves the Protective Effect of Glucagon-like Peptide-1 on Acute Hypoglycemia-Induced Oxidative Stress, Inflammation, and Endothelial Dysfunction in Type 1 Diabetes.
Low Prevalence of Sublinical Atherosclerosis in Asymptomatic Patients With Type 1 Diabetes Mellitus in a European Mediterranean Population.

October 15, 2013

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.
Characterization of residual beta-cell function in long standing type 1 diabetes.
Age-dependent decline of beta cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: Preliminary results.
Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial.
Islet transplantation in type 1 diabetes: hype, hope and reality – a clinician’s perspective.
Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. Free full text available in HTML and PDF formats.

October 9, 2013

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial.
Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls.
Non-invasive detection of microvascular changes in a paediatric and adolescent population with type 1 diabetes: a pilot cross-sectional study. Free full text available in PDF format.
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide-1 receptor on gastric emptying and glycaemia.

October 2, 2013

The Emerging Global Epidemic of Type 1 Diabetes.
Increasing burden, younger age at onset and worst metabolic control in migrant than in Italian children with type 1 diabetes: an emerging problem in pediatric clinics.
Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes..
Embedding islet in a liquid scaffold increases islet viability and function.
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes.

September 25, 2013

Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes. See also Low-Glucose-Suspension Feature Cuts Severe Hypoglycemia (Free Medscape membership required).
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. See also Psoriasis drug shows promising results for treating type 1 diabetes.
Infectious triggers in type 1 diabetes: is there a case for epitope mimicry?
Large European study suggests men with type 1 diabetes are better at blood sugar control than women.
Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus. Free full text available in HTML and PDF formats.
Under 20% of Donations Raised for a Cure Are Actually Allocated to Cure Research according to the Juvenile Diabetes Cure Alliance.

« Previous
1
…
47
48
49
50
51
…
94
Next »

advertisement

Last Updated: Saturday, June 14, 2025 15:24:09 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Email
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.